quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:00:00·365d
PRRelease
Biodesix Inc. logo
Bio-Rad Laboratories Inc. logo

Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

BDSX· Biodesix Inc.BIO· Bio-Rad Laboratories Inc.
Health CareIndustrials
Original source

Companies

  • BDSX
    Biodesix Inc.
    Health Care
  • BIO
    Bio-Rad Laboratories Inc.
    Industrials

Recent analyst ratings

  • Apr 7BIOUpdateCitigroup$300.00
  • Feb 27BDSXUpdateWilliam Blair-
  • May 14BDSXUpdateWilliam Blair-
  • Oct 1BIOUpdateCitigroup$400.00
  • Sep 16BDSXUpdateScotiabank-
  • Aug 28BIOUpdateWells Fargo$340.00

Related

  • PR3d
    Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026
  • PR7d
    Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026
  • SEC14d
    SEC Form DEFA14A filed by Biodesix Inc.
  • SEC14d
    SEC Form DEF 14A filed by Biodesix Inc.
  • PR14d
    Biodesix Recognized as a Top Workplace for Third Consecutive Year
  • ANALYST16d
    Bio-Rad Labs downgraded by Citigroup with a new price target
  • PR17d
    Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
  • INSIDER21d
    SEC Form 4 filed by Patience John
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022